Table of Contents
ISRN Gastroenterology
Volume 2013, Article ID 490578, 6 pages
http://dx.doi.org/10.1155/2013/490578
Research Article

Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy

1Medical Oncology, Propedeutic, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Mikras Asias 7, 11527 Athens, Greece
21st Department of Pathology, Propedeutic, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Mikras Asias 7, 11527 Athens, Greece
32nd Department of Medical Oncology, Metaxa Cancer Hospital, Mpotasi 51, 18537 Piraeus, Greece
4Gastroenterology Unit, Department of Pathophysiology, Propedeutic, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Mikras Asias 7, 11527 Athens, Greece
51st Department of Internal Medicine, Propedeutic, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Mikras Asias 7, 11527 Athens, Greece

Received 17 April 2013; Accepted 12 May 2013

Academic Editors: L. David, G.-T. Huang, F. Izzo, S. Ogino, and A. K. Rishi

Copyright © 2013 Ioannis D. Xynos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Cunningham, W. Atkin, H. Lenz et al., “Colorectal cancer,” The Lancet, vol. 375, no. 9719, pp. 1030–1047, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Parkin, “Global cancer statistics in the year 2000,” Lancet Oncology, vol. 2, no. 9, pp. 533–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Goldberg, M. L. Rothenberg, E. Van Cutsem et al., “The continuum of care: a paradigm for the management of metastatic colorectal cancer,” Oncologist, vol. 12, no. 1, pp. 38–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Field and L. Lipton, “Metastatic colorectal cancer-past, progress and future,” World Journal of Gastroenterology, vol. 13, no. 28, pp. 3806–3815, 2007. View at Google Scholar · View at Scopus
  6. P. Piedbois, M. Buyse, Y. Rustum et al., “Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate,” Journal of Clinical Oncology, vol. 10, no. 6, pp. 896–903, 1992. View at Google Scholar · View at Scopus
  7. A. L. Yuste, J. Aparicio, A. Segura et al., “Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy,” Clinical Colorectal Cancer, vol. 2, no. 4, pp. 231–234, 2003. View at Google Scholar · View at Scopus
  8. G. Pentheroudakis, G. Fountzilas, H. P. Kalofonos et al., “Palliative chemotherapy in elderly patients with common metastatic malignancies: a Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors,” Critical Reviews in Oncology/Hematology, vol. 66, no. 3, pp. 237–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Zacharakis, I. D. Xynos, A. Lazaris et al., “Predictors of survival in stage IV metastatic colorectal cancer,” Anticancer Research, vol. 30, no. 2, pp. 653–660, 2010. View at Google Scholar · View at Scopus
  10. J. Syrios, S. Sougioultzis, I. D. Xynos et al., “Survival in patients with stage IV noncardia gastric cancer-the influence of DNA ploidy and Helicobacter pylori infection,” BMC Cancer, vol. 12, p. 264, 2012. View at Publisher · View at Google Scholar
  11. G. Chelidonis, N. Kavantzas, E. Patsouris et al., “DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic significance in imprints of non-small cell lung cancer,” Analytical and Quantitative Cytology and Histology, vol. 31, no. 5, pp. 332–339, 2009. View at Google Scholar · View at Scopus
  12. D. C. McMillan, H. A. Wotherspoon, K. C. H. Fearon, C. Sturgeon, T. G. Cooke, and C. S. McArdle, “A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery,” American Journal of Surgery, vol. 170, no. 4, pp. 319–322, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Nozoe, T. Matsumata, M. Kitamura, and K. Sugimachi, “Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer,” American Journal of Surgery, vol. 176, no. 4, pp. 335–338, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Shiu, J. Lin, C. Huang et al., “Is C-reactive protein a prognostic factor of colorectal cancer?” Diseases of the Colon and Rectum, vol. 51, no. 4, pp. 443–449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Wigmore, A. J. MacMahon, C. M. Sturgeon, and K. C. H. Fearon, “Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer,” British Journal of Surgery, vol. 88, no. 2, pp. 255–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. G. Van de Poll, Y. L. B. Klaver, V. E. P. P. Lemmens, B. J. M. Leenders, S. W. Nienhuijs, and I. H. J. T. De Hingh, “C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin,” International Journal of Colorectal Disease, vol. 26, no. 8, pp. 1067–1073, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Chung and Y. Chang, “Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator,” Journal of Surgical Oncology, vol. 83, pp. 222–226, 2003. View at Google Scholar
  18. C. Köhne, D. Cunningham, F. Di Costanzo et al., “Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients,” Annals of Oncology, vol. 13, no. 2, pp. 308–317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Edler, M. E. Heim, and C. Quintero, “Prognostic factors of advanced colorectal cancer patients,” European Journal of Cancer and Clinical Oncology, vol. 22, no. 10, pp. 1231–1237, 1986. View at Google Scholar · View at Scopus
  20. J. Steinberg, C. Erlichman, T. Gadalla, S. Fine, and A. Wong, “Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid,” European Journal of Cancer A, vol. 28, no. 11, pp. 1817–1820, 1992. View at Google Scholar · View at Scopus
  21. L. Assersohn, A. Norman, D. Cunningham, T. Benepal, P. J. Ross, and J. Oates, “Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma,” British Journal of Cancer, vol. 79, no. 11-12, pp. 1800–1805, 1999. View at Google Scholar · View at Scopus
  22. R. Díaz, J. Aparicio, R. Gironés et al., “Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin-based chemotherapy,” Clinical Colorectal Cancer, vol. 5, no. 3, pp. 197–202, 2005. View at Google Scholar · View at Scopus
  23. C. J. Lahr, S. J. Soong, and G. Cloud, “A multifactoral analysis of prognostic factors in patients with liver metastases from colorectal carcinoma,” Journal of Clinical Oncology, vol. 1, no. 11, pp. 720–726, 1983. View at Google Scholar · View at Scopus
  24. G. Y. Locker, S. Hamilton, J. Harris et al., “ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer,” Journal of Clinical Oncology, vol. 24, no. 33, pp. 5313–5327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Porschen, U. Remy, G. Bevers, S. Schauseil, K. J. Hengels, and F. Borchard, “Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas: a flow cytometric study of paraffin-embedded specimens,” Cancer, vol. 71, no. 12, pp. 3846–3850, 1993. View at Google Scholar · View at Scopus
  26. D. Nori, O. Merimsky, E. Samala et al., “Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated Dukes' B2 colon cancer patients,” Journal of Surgical Oncology, vol. 59, no. 4, pp. 239–242, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. E. W. Kay, H. E. Mulcahy, B. Curran, D. P. O'Donoghue, and M. Leader, “An image analysis study of DNA content in early colorectal cancer,” European Journal of Cancer, vol. 32, no. 4, pp. 612–616, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Buhmeida, M. Hilska, A. Elzagheid et al., “DNA image cytometry predicts disease outcome in stage II colorectal carcinoma,” Anticancer Research, vol. 29, no. 1, pp. 99–106, 2009. View at Google Scholar · View at Scopus
  29. A. Walther, R. Houlston, and I. Tomlinson, “Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis,” Gut, vol. 57, no. 7, pp. 941–950, 2008. View at Publisher · View at Google Scholar · View at Scopus